Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.

Necchi A, Madison R, Raggi D, Jacob JM, Bratslavsky G, Shapiro O, Elvin JA, Vergilio JA, Killian JK, Ngo N, Ramkissoon S, Severson E, Hemmerich AC, Huang R, Ali SM, Chung JH, Reddy P, Miller VA, Schrock AB, Gay LM, Alexander BM, Grivas P, Ross JS.

Eur Urol. 2020 Jan 17. pii: S0302-2838(20)30003-8. doi: 10.1016/j.eururo.2020.01.003. [Epub ahead of print]

PMID:
31959546
2.

Human Cytomegalovirus Latency and Myelosuppression: A microRNA-Dependent Yin and Yang Regulatory Loop.

Gay L, Renne R.

Cell Host Microbe. 2020 Jan 8;27(1):8-10. doi: 10.1016/j.chom.2019.12.008.

PMID:
31951824
3.

PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment.

Naipauer J, Rosario S, Gupta S, Premer C, Méndez-Solís O, Schlesinger M, Ponzinibbio V, Jain V, Gay L, Renne R, Chan HL, Morey L, Salyakina D, Abba M, Williams S, Hare JM, Goldschmidt-Clermont PJ, Mesri EA.

PLoS Pathog. 2019 Dec 27;15(12):e1008221. doi: 10.1371/journal.ppat.1008221. [Epub ahead of print]

4.

Plasma membrane tension regulates eisosome structure and function.

Appadurai D, Gay L, Moharir A, Lang MJ, Duncan MC, Schmidt O, Teis D, Vu TN, Silva M, Jorgensen EM, Babst M.

Mol Biol Cell. 2019 Dec 18:mbcE19040218. doi: 10.1091/mbc.E19-04-0218. [Epub ahead of print]

PMID:
31851579
5.

Sexual and reproductive health of adolescents in schools for people with disabilities.

Obasi M, Manortey S, Kyei KA, Addo MK, Talboys S, Gay L, Baiden F.

Pan Afr Med J. 2019 Aug 14;33:299. doi: 10.11604/pamj.2019.33.299.18546. eCollection 2019.

6.

MLH1 deficiency leads to deregulated mitochondrial metabolism.

Rashid S, Freitas MO, Cucchi D, Bridge G, Yao Z, Gay L, Williams M, Wang J, Suraweera N, Silver A, McDonald SAC, Chelala C, Szabadkai G, Martin SA.

Cell Death Dis. 2019 Oct 22;10(11):795. doi: 10.1038/s41419-019-2018-y.

7.

Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.

Valiakhmetova A, Gorelyshev S, Konovalov A, Trunin Y, Savateev A, Kram DE, Severson E, Hemmerich A, Edgerly C, Duncan D, Britt N, Huang RSP, Elvin J, Miller V, Ross JS, Gay L, McCorkle J, Rankin A, Erlich RL, Chudnovsky Y, Ramkissoon SH.

Oncologist. 2019 Oct 16. pii: theoncologist.2019-0603. doi: 10.1634/theoncologist.2019-0603. [Epub ahead of print] Review.

8.

The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA.

Disel U, Madison R, Abhishek K, Chung JH, Trabucco SE, Matos AO, Frampton GM, Albacker LA, Reddy V, Karadurmus N, Benson A, Webster J, Paydas S, Cabanillas R, Nangia C, Ozturk MA, Millis SZ, Pal SK, Wilky B, Sokol ES, Gay LM, Soman S, Ganesan S, Janeway K, Stephens PJ, Zhu VW, Ou SI, Lovly CM, Gounder M, Schrock AB, Ross JS, Miller VA, Klempner SJ, Ali SM.

Oncologist. 2020 Jan;25(1):e39-e47. doi: 10.1634/theoncologist.2018-0528. Epub 2019 Oct 11.

9.

Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study.

Navarria P, Pessina F, Clerici E, Franceschini D, Gay LG, De Rose F, Renna I, D'Agostino G, Franzese C, Comito T, Tomatis S, Nibali MC, Leonetti A, Puglisi G, Bello L, Scorsetti M.

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1095-1105. doi: 10.1016/j.ijrobp.2019.08.054. Epub 2019 Aug 31.

PMID:
31479701
10.

Resection of tumors within the primary motor cortex using high-frequency stimulation: oncological and functional efficiency of this versatile approach based on clinical conditions.

Rossi M, Conti Nibali M, Viganò L, Puglisi G, Howells H, Gay L, Sciortino T, Leonetti A, Riva M, Fornia L, Cerri G, Bello L.

J Neurosurg. 2019 Aug 9:1-13. doi: 10.3171/2019.5.JNS19453. [Epub ahead of print]

PMID:
31398706
11.

Identification of murine gammaherpesvirus 68 miRNA-mRNA hybrids reveals miRNA target conservation among gammaherpesviruses including host translation and protein modification machinery.

Bullard WL, Kara M, Gay LA, Sethuraman S, Wang Y, Nirmalan S, Esemenli A, Feswick A, Hoffman BA, Renne R, Tibbetts SA.

PLoS Pathog. 2019 Aug 8;15(8):e1007843. doi: 10.1371/journal.ppat.1007843. eCollection 2019 Aug.

12.

Intraoperative Computed Tomography and Finite Element Modelling for Multimodal Image Fusion in Brain Surgery.

Riva M, Hiepe P, Frommert M, Divenuto I, Gay LG, Sciortino T, Nibali MC, Rossi M, Pessina F, Bello L.

Oper Neurosurg (Hagerstown). 2019 Jul 25. pii: opz196. doi: 10.1093/ons/opz196. [Epub ahead of print]

PMID:
31342073
13.

How does selfing affect the genetic variance of quantitative traits? An updated meta-analysis on empirical results in angiosperm species.

Clo J, Gay L, Ronfort J.

Evolution. 2019 Aug;73(8):1578-1590. doi: 10.1111/evo.13789. Epub 2019 Jun 17.

PMID:
31206658
14.

Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors.

Necchi A, Bratslavsky G, Shapiro O, Elvin JA, Vergilio JA, Killian JK, Ngo N, Ramkissoon S, Severson E, Hemmerich AC, Ali SM, Chung JH, Reddy P, Miller VA, Schrock AB, Gay LM, Ross JS, Jacob JM.

Eur Urol Focus. 2019 Sep;5(5):748-755. doi: 10.1016/j.euf.2019.05.012. Epub 2019 May 27.

PMID:
31147264
15.

Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome.

Rossi M, Ambrogi F, Gay L, Gallucci M, Conti Nibali M, Leonetti A, Puglisi G, Sciortino T, Howells H, Riva M, Pessina F, Navarria P, Franzese C, Simonelli M, Rudà R, Bello L.

J Neurosurg. 2019 May 17:1-14. doi: 10.3171/2019.2.JNS183408. [Epub ahead of print]

PMID:
31100730
16.

Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies.

Gaillard SL, Andreano KJ, Gay LM, Steiner M, Jorgensen MS, Davidson BA, Havrilesky LJ, Alvarez Secord A, Valea FA, Colon-Otero G, Zajchowski DA, Chang CY, McDonnell DP, Berchuck A, Elvin JA.

Gynecol Oncol. 2019 Jul;154(1):199-206. doi: 10.1016/j.ygyno.2019.04.010. Epub 2019 Apr 13.

PMID:
30987772
17.

[Eating disorders].

Gay L, Satori N.

Rev Infirm. 2019 Jan;68(247):16-18. doi: 10.1016/j.revinf.2018.11.002. French.

PMID:
30910110
18.

The sexual dimorphism of anticardiolipin autoantibodies in acute Q fever patients.

Melenotte C, Gay L, Mezouar S, Bardin N, Raoult D, Mège JL.

Clin Microbiol Infect. 2019 Jun;25(6):763.e1-763.e3. doi: 10.1016/j.cmi.2019.02.030. Epub 2019 Mar 18.

PMID:
30898724
19.

Frameless stereotactic biopsy for precision neurosurgery: diagnostic value, safety, and accuracy.

Sciortino T, Fernandes B, Conti Nibali M, Gay LG, Rossi M, Lopci E, Colombo AE, Elefante MG, Pessina F, Bello L, Riva M.

Acta Neurochir (Wien). 2019 May;161(5):967-974. doi: 10.1007/s00701-019-03873-w. Epub 2019 Mar 20.

PMID:
30895395
20.

Structure of multilocus genetic diversity in predominantly selfing populations.

Jullien M, Navascués M, Ronfort J, Loridon K, Gay L.

Heredity (Edinb). 2019 Aug;123(2):176-191. doi: 10.1038/s41437-019-0182-6. Epub 2019 Jan 22.

PMID:
30670844
21.

Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.

Necchi A, Bratslavsky G, Chung J, Millis S, Gay LM, Ali SM, Ross JS.

Oncologist. 2019 Apr;24(4):e142-e145. doi: 10.1634/theoncologist.2018-0430. Epub 2019 Jan 18.

22.

Discontinuities in quinoa biodiversity in the dry Andes: An 18-century perspective based on allelic genotyping.

Winkel T, Aguirre MG, Arizio CM, Aschero CA, Babot MDP, Benoit L, Burgarella C, Costa-Tártara S, Dubois MP, Gay L, Hocsman S, Jullien M, López-Campeny SML, Manifesto MM, Navascués M, Oliszewski N, Pintar E, Zenboudji S, Bertero HD, Joffre R.

PLoS One. 2018 Dec 5;13(12):e0207519. doi: 10.1371/journal.pone.0207519. eCollection 2018.

23.

RET rearrangements are actionable alterations in breast cancer.

Paratala BS, Chung JH, Williams CB, Yilmazel B, Petrosky W, Williams K, Schrock AB, Gay LM, Lee E, Dolfi SC, Pham K, Lin S, Yao M, Kulkarni A, DiClemente F, Liu C, Rodriguez-Rodriguez L, Ganesan S, Ross JS, Ali SM, Leyland-Jones B, Hirshfield KM.

Nat Commun. 2018 Nov 16;9(1):4821. doi: 10.1038/s41467-018-07341-4.

24.

Contemporary Ribonomics Methods for Viral microRNA Target Analysis.

Gay LA, Turner PC, Renne R.

Noncoding RNA. 2018 Nov 9;4(4). pii: E31. doi: 10.3390/ncrna4040031. Review.

25.

Impact of a Resident-Centered Interprofessional Quality Improvement Intervention on Acute Care Length of Stay.

Walker M, Gay L, Raynaldo G, Von Marensdorff H, Bates JT, Friedland JA, Park JH, Kehl E, Sowers B, Bhavani S, Lan C, Bozkurt B, Stewart DE, Horstman MJ.

J Healthc Qual. 2019 Jul/Aug;41(4):212-219. doi: 10.1097/JHQ.0000000000000156.

PMID:
30383558
26.

Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.

Jacob JM, Ferry EK, Gay LM, Elvin JA, Vergilio JA, Ramkissoon S, Severson E, Necchi A, Killian JK, Ali SM, Schrock AB, Liu NW, Chung J, Miller VA, Stephens PJ, Welsh A, Corona RJ, Ross JS, Bratslavsky G.

J Urol. 2019 Mar;201(3):541-548. doi: 10.1016/j.juro.2018.09.056.

PMID:
30291913
27.

Preoperative surgical planning of glioma: limitations and reliability of fMRI and DTI tractography.

Conti Nibali M, Rossi M, Sciortino T, Riva M, Gay LG, Pessina F, Bello L.

J Neurosurg Sci. 2019 Apr;63(2):127-134. doi: 10.23736/S0390-5616.18.04597-6. Epub 2018 Oct 2. Review.

PMID:
30290696
28.

Genomic Landscape of Adult and Pediatric BCR-ABL1-Like B-Lymphoblastic Leukemia Using Parallel DNA and RNA Sequencing.

Severson EA, Vergilio JA, Gay LM, Daniel S, Hemmerich AC, Elvin JA, Britt N, Nahas M, Cohen MB, Brown C, Sathyan P, Rankin A, Miller V, Ross JS, Ramkissoon SH.

Oncologist. 2019 Mar;24(3):372-374. doi: 10.1634/theoncologist.2018-0272. Epub 2018 Sep 4.

29.

Analysis of MDM2 Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies.

Kato S, Ross JS, Gay L, Dayyani F, Roszik J, Subbiah V, Kurzrock R.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00235. Epub 2018 Jul 13.

30.

Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.

Necchi A, Bratslavsky G, Corona RJ, Chung JH, Millis SZ, Elvin JA, Vergilio JA, Suh J, Ramkissoon S, Severson E, Daniel S, Killian JK, Ali SM, Schrock AB, Reddy P, Miller VA, Welsh A, Gay LM, Ross JS.

Eur Urol Focus. 2020 Jan 15;6(1):122-130. doi: 10.1016/j.euf.2018.07.013. Epub 2018 Jul 17.

PMID:
30025711
31.

Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.

Ramkissoon LA, Britt N, Guevara A, Whitt E, Severson E, Sathyan P, Gay L, Elvin J, Ross JS, Brown C, Stogner-Underwood K, Mott R, Kram D, Strowd R, Lesser GJ, Ramkissoon SH.

Curr Treat Options Oncol. 2018 Jun 21;19(8):41. doi: 10.1007/s11864-018-0559-4. Review.

PMID:
29931654
32.

Eisosomes are metabolically regulated storage compartments for APC-type nutrient transporters.

Moharir A, Gay L, Appadurai D, Keener J, Babst M.

Mol Biol Cell. 2018 Aug 15;29(17):2113-2127. doi: 10.1091/mbc.E17-11-0691. Epub 2018 Jun 21.

33.

Biophysical Characterization of the Tandem FHA Domain Regulatory Module from the Mycobacterium tuberculosis ABC Transporter Rv1747.

Heinkel F, Shen L, Richard-Greenblatt M, Okon M, Bui JM, Gee CL, Gay LM, Alber T, Av-Gay Y, Gsponer J, McIntosh LP.

Structure. 2018 Jul 3;26(7):972-986.e6. doi: 10.1016/j.str.2018.04.018. Epub 2018 May 31.

34.

Computational analysis of ribonomics datasets identifies long non-coding RNA targets of γ-herpesviral miRNAs.

Sethuraman S, Thomas M, Gay LA, Renne R.

Nucleic Acids Res. 2018 Sep 19;46(16):8574-8589. doi: 10.1093/nar/gky459.

35.

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV.

Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.

36.

Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens.

Severson EA, Riedlinger GM, Connelly CF, Vergilio JA, Goldfinger M, Ramkissoon S, Frampton GM, Ross JS, Fratella-Calabrese A, Gay L, Ali S, Miller V, Elvin J, Hadigol M, Hirshfield KM, Rodriguez-Rodriguez L, Ganesan S, Khiabanian H.

Blood. 2018 May 31;131(22):2501-2505. doi: 10.1182/blood-2018-03-840629. Epub 2018 Apr 20. No abstract available.

37.

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.

Pozdeyev N, Gay LM, Sokol ES, Hartmaier R, Deaver KE, Davis S, French JD, Borre PV, LaBarbera DV, Tan AC, Schweppe RE, Fishbein L, Ross JS, Haugen BR, Bowles DW.

Clin Cancer Res. 2018 Jul 1;24(13):3059-3068. doi: 10.1158/1078-0432.CCR-18-0373. Epub 2018 Apr 3.

38.

Anaplastic Lymphoma Kinase Mutation (ALK F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to Alectinib.

Carneiro BA, Pamarthy S, Shah AN, Sagar V, Unno K, Han H, Yang XJ, Costa RB, Nagy RJ, Lanman RB, Kuzel TM, Ross JS, Gay L, Elvin JA, Ali SM, Cristofanilli M, Chae YK, Giles FJ, Abdulkadir SA.

Clin Cancer Res. 2018 Jun 15;24(12):2732-2739. doi: 10.1158/1078-0432.CCR-18-0332. Epub 2018 Mar 20.

39.

Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care Testing.

Suh JH, Schrock AB, Johnson A, Lipson D, Gay LM, Ramkissoon S, Vergilio JA, Elvin JA, Shakir A, Ruehlman P, Reckamp KL, Ou SI, Ross JS, Stephens PJ, Miller VA, Ali SM.

Oncologist. 2018 Jul;23(7):776-781. doi: 10.1634/theoncologist.2017-0493. Epub 2018 Mar 14.

40.

Viral load, tissue distribution and histopathological lesions in goats naturally and experimentally infected with the Small Ruminant Lentivirus Genotype E (subtype E1 Roccaverano strain).

Grego E, Reina R, Lanfredini S, Tursi M, Favole A, Profiti M, Lungu MM, Perona G, Gay L, Stella MC, DeMeneghi D.

Res Vet Sci. 2018 Jun;118:107-114. doi: 10.1016/j.rvsc.2018.01.008. Epub 2018 Jan 31.

41.

Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.

Gay LA, Sethuraman S, Thomas M, Turner PC, Renne R.

J Virol. 2018 Mar 28;92(8). pii: e02138-17. doi: 10.1128/JVI.02138-17. Print 2018 Apr 15.

42.

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.

Hartmaier RJ, Trabucco SE, Priedigkeit N, Chung JH, Parachoniak CA, Vanden Borre P, Morley S, Rosenzweig M, Gay LM, Goldberg ME, Suh J, Ali SM, Ross J, Leyland-Jones B, Young B, Williams C, Park B, Tsai M, Haley B, Peguero J, Callahan RD, Sachelarie I, Cho J, Atkinson JM, Bahreini A, Nagle AM, Puhalla SL, Watters RJ, Erdogan-Yildirim Z, Cao L, Oesterreich S, Mathew A, Lucas PC, Davidson NE, Brufsky AM, Frampton GM, Stephens PJ, Chmielecki J, Lee AV.

Ann Oncol. 2018 Apr 1;29(4):872-880. doi: 10.1093/annonc/mdy025.

43.

Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement.

Bellone S, Buza N, Choi J, Zammataro L, Gay L, Elvin J, Rimm DL, Liu Y, Ratner ES, Schwartz PE, Santin AD.

Clin Cancer Res. 2018 Jul 15;24(14):3282-3291. doi: 10.1158/1078-0432.CCR-17-1805. Epub 2018 Jan 19.

44.

Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.

Ross JS, Fakih M, Ali SM, Elvin JA, Schrock AB, Suh J, Vergilio JA, Ramkissoon S, Severson E, Daniel S, Fabrizio D, Frampton G, Sun J, Miller VA, Stephens PJ, Gay LM.

Cancer. 2018 Apr 1;124(7):1358-1373. doi: 10.1002/cncr.31125. Epub 2018 Jan 16.

45.

BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy.

Gornstein EL, Sandefur S, Chung JH, Gay LM, Holmes O, Erlich RL, Soman S, Martin LK, Rose AV, Stephens PJ, Ross JS, Miller VA, Ali SM, Blau S.

Clin Breast Cancer. 2018 Apr;18(2):184-188. doi: 10.1016/j.clbc.2017.12.010. Epub 2017 Dec 21. No abstract available.

PMID:
29325860
46.

Author Correction: Intermediate degrees of synergistic pleiotropy drive adaptive evolution in ecological time.

Frachon L, Libourel C, Villoutreix R, Carrère S, Glorieux C, Huard-Chauveau C, Navascués M, Gay L, Vitalis R, Baron E, Amsellem L, Bouchez O, Vidal M, Le Corre V, Roby D, Bergelson J, Roux F.

Nat Ecol Evol. 2018 Jan;2(1):194. doi: 10.1038/s41559-017-0405-2.

PMID:
29208992
47.

Intermediate degrees of synergistic pleiotropy drive adaptive evolution in ecological time.

Frachon L, Libourel C, Villoutreix R, Carrère S, Glorieux C, Huard-Chauveau C, Navascués M, Gay L, Vitalis R, Baron E, Amsellem L, Bouchez O, Vidal M, Le Corre V, Roby D, Bergelson J, Roux F.

Nat Ecol Evol. 2017 Oct;1(10):1551-1561. doi: 10.1038/s41559-017-0297-1. Epub 2017 Sep 4. Erratum in: Nat Ecol Evol. 2017 Dec 5;:.

PMID:
29185515
48.

Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type.

Lin DI, Chudnovsky Y, Duggan B, Zajchowski D, Greenbowe J, Ross JS, Gay LM, Ali SM, Elvin JA.

Gynecol Oncol. 2017 Dec;147(3):626-633. doi: 10.1016/j.ygyno.2017.09.031. Epub 2017 Nov 6.

PMID:
29102090
49.

ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.

Ross JS, Ali SM, Fasan O, Block J, Pal S, Elvin JA, Schrock AB, Suh J, Nozad S, Kim S, Jeong Lee H, Sheehan CE, Jones DM, Vergilio JA, Ramkissoon S, Severson E, Daniel S, Fabrizio D, Frampton G, Miller VA, Stephens PJ, Gay LM.

Oncologist. 2017 Dec;22(12):1444-1450. doi: 10.1634/theoncologist.2016-0488. Epub 2017 Oct 27.

50.

General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study.

Lee H, El Jabbour T, Ainechi S, Gay LM, Elvin JA, Vergilio JA, Suh J, Ramkissoon SH, Ali SM, Schrock A, Fabrizio D, Frampton G, Nazeer T, Miller VA, Stephens PJ, Ross JS.

Hum Pathol. 2017 Dec;70:84-91. doi: 10.1016/j.humpath.2017.10.007. Epub 2017 Oct 24.

PMID:
29079173

Supplemental Content

Support Center